Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04218123

Recruitment Status : Completed

First Posted : January 6, 2020

Last Update Posted : September 28, 2023

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborators:

American Hearing Research Foundation

Cures within Reach Foundation

Information provided by (Responsible Party):

Habib Rizk,MD, Medical University of South Carolina

Results Submitted - Quality Control (QC) Review Has Not Concluded

Results information for an applicable clinical trial (ACT) is posted within 30 days of submission even if the submission has not completed the ClinicalTrials.gov Results Quality Control (QC) review process. Results information is submitted to ClinicalTrials.gov by the sponsor or investigator, and National Library of Medicine (NLM) staff assess for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.

All versions of ACT results information submissions that have not completed the QC review process are posted on ClinicalTrials.gov (since January 2020). After the QC review process is completed, the results information is posted without QC review comments and previous versions are archived.

Recruitment Status :	Completed
Actual Primary Completion Date :	September 13, 2023
Actual Study Completion Date :	September 14, 2023

Submission Cycle	Results Submitted to ClinicalTrials.gov	Results Returned after Quality Control Review
1	March 28, 2024	April 24, 2024 Submission with QC Comments
2	April 24, 2024

To Top